本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Achilles Therapeutics plc

1.48
+0.0000
成交量:- -
成交额:- -
市值:6,082.81万
市盈率:-0.89
高:1.48
开:1.48
低:1.48
收:1.48
数据加载中...
2024/03/29

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/03/08

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/07

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/30

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/23

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/15

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/11/15

SEC问询函

CORRESP [Cover] - Correspondence
2022/07/25

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/01

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals